A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset

American Journal of Human Genetics

Volumn 62, Issue 4, 1998, Pages 842-847

  Lalioti, Maria D ^a   Scott, Hamish S ^a   Genton, Pierre ^e   Grid, Djamel ^f   Ouazzani, Réda ^c   M'Rabet, Amel ^d   Ibrahim, Sadi ^f   Gouider, Riadh ^d   Dravet, Charlotte ^e   Chkili, Taieb ^c   Bottani, Armand ^b   Buresi, Catherine ^a   Malafosse, Alain ^a   Antonarakis, Stylianos E ^a,b,g  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c IBN SINA HOSPITAL   (Morocco)

^d CHARLES NICOLLE HOSPITAL   (Tunisia)

^e CENTRE SAINT PAUL   (France)

^f CHU Mustapha   (Algeria)

^g CMU   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC STABILITY; HUMAN; MYOCLONUS EPILEPSY; NUCLEOTIDE REPEAT; ONSET AGE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ATAXIA;

EID: 17344372332     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301798     Document Type: Article

References (18)

1. Ashley CT, Warren ST (1995) Trinucleotide repeat expansion and human disease. Annu Rev Genet 29:703-728
2. Brown WT, Houck GE Jr, Jeziorowska A, Levinson FN, Ding X, Dobkin C, Zhong N, et al (1993) Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 270:1569-1575
3. Chong SS, Eichler EE, Nelson DL, Hughes MR (1994) Robust amplification and ethidium-visible detection of the fragile X syndrome CGG repeat using Pfu polymerase. Am J Med Genet 51:522-526
4. Filla A, De Michele G, Cavalcanti F, Pianese L, Monticelli A, Campanella G, Cocozza S (1996) The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet 59:554-560
5. Lafrenière RG, Rochefort DL, Chrétien N, Rommens JM, Cochius JI, Kälviäinen R, Nousiainen U, et al (1997) Unstable insertion in the 5′ flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nat Genet 15:298-302
6. Lalioti MD, Mirotsou M, Buresi C, Peitsch MC, Rossier C, Ouazzani R, Baldy-Moulinier M, et al (1997a) Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1). Am J Hum Genet 60:342-351
7. Lalioti MD, Scott HS, Antonarakis SE (1997b) What is expanded in progressive myoclonus epilepsy? Nat Genet 17: 17
8. Lalioti MD, Scott HS, Buresi C, Rossier C, Bottani A, Morris MA, Malafosse A, et al (1997c) Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 386:847-852
9. Lamont PJ, Davis MB, Wood NW (1997) Identification and sizing of the GAA trinucleotide repeat expansion of Friedreich's ataxia in 56 patients: clinical and genetic correlates. Brain 120:673-680
10. Levinson G, Maddalena A, Palmer FT, Harton GL, Bick DP, Howard-Peebles PN, Black SH, et al (1994) Improved sizing of fragile X CCG repeats by nested polymerase chain reaction. Am J Med Genet 51:527-534
11. Malafosse A, Lehesjoki AE, Genton P, Labauge P, Durand G, Tassinari CA, Dravet C, et al (1992) Identical genetic locus for Baltic and Mediterranean myoclonus. Lancet 339: 1080-1081
12. Monros E, Molto MD, Martinez F, Canizares J, Blanca J, Vilchez JJ, Prieto F, et al (1997) Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat. Am J Hum Genet 61:101-110
13. Montermini L, Richter A, Morgan K, Justice CM, Julien D, Castellotti B, Mercier J, et al (1997) Phenotypic variability in Friedreich's ataxia: role of the associated GAA triplet repeat expansion. Ann Neurol 41:675-682
14. Paulson HL, Fischbeck KH (1996) Trinucleotide repeats in neurogenetic disorders. Annu Rev Neurosci 19:79-107
15. Pennacchio LA, Lehesjoki A-E, Stone NE, Willour VL, Virtaneva K, Miao J, D'Amato E, et al (1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271:1731-1734
16. Richards RI, Sutherland GR (1992) Dynamic mutations: a new class of mutations causing human disease. Cell 70:709-712
17. Turk V, Bode W (1991) The cystatins: protein inhibitors of cysteine proteinases. FEBS 285:213-219
18. Virtaneva K, D'Amato E, Miao J, Koskiniemi M, Norio R, Avanzini G, Franceschetti S, et al (1997) Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet 15:393-396